Release of prostaglandin E(2) and nitric oxide from spinal microglia is dependent on activation of p38

Tomohiro Matsui1, Camilla I Svensson, Yuka Hirata

  • 1Department of Laboratory Sciences, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.

Abstract

Insights

Spinal microglia activation via Toll-like receptor 4 (TLR4) releases prostaglandin E2 (PGE2) and nitric oxide (NO). This release is regulated by p38 and NO synthase 2 (NOS2), highlighting p38's role in pain signaling.

Area of Science:

  • Neuroscience
  • Immunology
  • Pain Research

Background:

  • Spinal prostaglandins (PGs), nitric oxide (NO), and cytokines are involved in pain processing.
  • Microglia, the immune cells of the central nervous system, are potential sources of these pain-mediating substances.
  • Spinal microglia express Toll-like receptor 4 (TLR4) and neurokinin 1 (NK1) receptors, implicated in spinal sensitization following nerve injury or inflammation.

Purpose of the Study:

  • To investigate the signaling pathways in cultured rat spinal microglia activated by TLR4 and NK1 receptors.
  • To determine the production of prostaglandin E2 (PGE2) and nitric oxide (NO) in response to these activations.
  • To elucidate the roles of cyclooxygenase (COX), NO synthase 2 (NOS2), and p38 mitogen-activated protein kinase (p38) in these responses.

Main Methods:

  • Primary cultures of rat spinal microglia were treated with lipopolysaccharide (LPS, a TLR4 ligand) and/or substance P (SP, an NK1 agonist).
  • Inhibitors of COX (SC-560, SC-236), NOS2 (1400W), p38 (SB203580), and minocycline were used to block specific pathways.
  • PGE2 and nitrite (NO marker) concentrations in culture supernatants were measured via enzyme immunoassay and colorimetric assay.

Main Results:

  • LPS stimulation dose-dependently increased PGE2 and NO2- production, while SP had no effect alone or with LPS.
  • LPS-induced PGE2 release involved both COX-1 and COX-2.
  • LPS-induced NO release was inhibited by 1400W (NOS2 inhibitor).
  • Minocycline and the p38 inhibitor SB203580 attenuated both LPS-induced PGE2 and NO release.
  • Inhibition of NOS2 also blocked the increased PGE2 release, suggesting cross-talk between pathways.

Conclusions:

  • Activation of spinal microglia via TLR4, not NK1, triggers the release of PGE2 and NO.
  • Both COX-1 and COX-2 contribute to LPS-induced PGE2 production.
  • The COX-PGE2 pathway is modulated by p38 and NOS2.
  • p38 in spinal microglia is a critical regulator of pronociceptive molecule production (PGE2, NO), reinforcing its role in pain signaling.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...